Table 2 Evaluation of the echocardiographic variables of the two groups

LVEDV, ml (± sd)

94 (21.9)

92.8 (24.8)

94.4 (21)

0.70

LVEDD, mm (± sd)

42.2 (4.6)

42 (5)

42.3 (4.4)

0.77

LVESV, ml (± sd)

32.9 (10.2)

33.5 (12.9)

32.8 (9.3)

0.71

LVEF, % (± sd)

64.4 (5.4)

63.8 (6.5)

64.(5)

0.47

LVthick, mm(± sd)

18.7 (4.4)

20.1 (5.5)

18.1 (3.8)

0.004*

LAD, mm (± sd)

39.2 (5.5)

41.9 (5.1)

38.3 (5.4)

0.001*

LAVmax, ml (± sd)

79.7 (27.1)

86.6 (23.7)

77.3 (27.8)

0.013*

LAA, cmq (± sd)

23.7 (5.2)

25.7 (4.8)

23.1 (5.3)

0.004*

LAVmin, ml (± sd)

44 (21.2)

55.3 (19)

40.3 (20.8)

< 0.001*

LAEF, % (± sd)

46 (12)

37 (10)

49 (11)

< 0.001*

LACI (± sd)

48 (21)

62 (20)

43 (19)

< 0.001*

E vel, cm/s (± sd)

81 (25)

81 (24)

82 (25)

0.82

A vel, cm/s (± sd)

70 (30)

61 (28)

74 (30)

0.042*

DT, ms(± sd)

213 (71.9)

211 (75)

214 (71)

0.84

E/e’ (± sd)

14.1 (7.4)

16.2 (8.6)

23.5 (6.8)

0.08

TAPSE, mm (± sd)

22 (3.4)

22 (2.7)

22 (3.6)

0.46

SPAP, mmHg (± sd)

32 (10.8)

33 (10.2)

31 (11.1)

0.44

LVOT grad, mmHg (± sd)

25 (29.8)

24 (30)

26 (29.9)

0.79

MR -/1 + /2 + 

56/64/21

12/14/10

44/50/11

0.15

AR -/1 + /2 + /3 + /4 + 

122/15/4/-/-

28/6/1/-/-

94/9/3/-/-

0.35

TR -/1 + /2 + /3 + /4 + 

89/44/8/-/-

25/7/3/-/-

64/37/5/-/-

0.22